Developmental guidance of embryonic corneal innervation: roles of Semaphorin3A and Slit2.
The cornea is one of the most densely innervated structures of the body. In the developing chicken embryo, nerves from the ophthalmic trigeminal ganglion (OTG) innervate the cornea in a series of spatially and temporally regulated events. However, little is known concerning the signals that regulate these events. Here we have examined the involvement of the axon guidance molecules Semaphorin3A and Slit2, and their respective receptors, Neuropilin-1 and Robo2. Expression analyses of early corneas suggest an involvement of both Semaphorin3A and Slit2 in preventing nerves from entering the corneal stroma until the proper time (i.e., they serve as negative regulators), and analyses of their receptors support this conclusion. At later stages of development the expression of Semaphorin3A is again consistent with its serving as a negative regulator-this time for nerves entering the corneal epithelium. However, expression analyses of Robo2 at this stage raised the possibility that Slit2 had switched from a negative regulator to a positive regulator. In support of such a switch, functional analyses-by addition of recombinant Slit2 protein or immunoneutralization with a Slit2 antibody-showed that at an early stage Slit2 negatively regulates the outgrowth of nerves from the OTG, whereas at the later stage it positively regulated the growth of nerves by increasing nerve branching within the corneal epithelium.
Kubilus
James K
JK
Department of Anatomy and Cellular Biology, Sackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, 136 Harrison Ave, Boston, MA 02111, USA.
Linsenmayer
Thomas F
TF
D000818:Animals; D002642:Chick Embryo; D003315:Cornea / Q000196:embryology* / Q000294:innervation*; D017931:DNA Primers / Q000737:chemistry; D018507:Gene Expression Regulation, Developmental; D007150:Immunohistochemistry / Q000379:methods; D017403:In Situ Hybridization; D036341:Intercellular Signaling Peptides and Proteins / Q000378:metabolism*; D051379:Mice; D008954:Models, Biological; D009419:Nerve Tissue Proteins / Q000378:metabolism*; D016501:Neurites / Q000378:metabolism; D011971:Receptors, Immunologic / Q000378:metabolism; D011994:Recombinant Proteins / Q000737:chemistry; D020133:Reverse Transcriptase Polymerase Chain Reaction; D040121:Semaphorin-3A / Q000502:physiology*; D000098552:Slit Homolog 2 Protein
D017931:DNA Primers; D036341:Intercellular Signaling Peptides and Proteins; D009419:Nerve Tissue Proteins; D011971:Receptors, Immunologic; D011994:Recombinant Proteins; D040121:Semaphorin-3A; D000098552:Slit Homolog 2 Protein
Cell Motil Cytoskeleton. 1990;17(2):118-32
2257630
Development. 1997 Apr;124(7):1377-85
9118808
J Neurosci. 2002 Jun 1;22(11):4540-9
12040061
Science. 1996 Nov 15;274(5290):1123-33
8895455
J Neurobiol. 2002 Apr;51(1):43-53
11920727
J Comp Neurol. 1995 Oct 16;361(2):321-33
8543665
Pathol Immunopathol Res. 1988;7(1-2):14-9
3065766
Dev Biol. 2000 Apr 15;220(2):424-31
10753528
Neuron. 2001 Oct 11;32(1):25-38
11604136
Am J Ophthalmol. 2001 Sep;132(3):405-6
11530056
J Neurophysiol. 1993 May;69(5):1779-83
8509835
Cell. 1993 Oct 22;75(2):217-27
8402908
Exp Eye Res. 2009 Dec;89(6):854-62
19627987
Invest Ophthalmol Vis Sci. 1985 Jun;26(6):818-27
3924852
Dev Dyn. 2003 Dec;228(4):726-33
14648849
J Morphol. 1951 Jan;88(1):49-92
24539719
Eur J Neurosci. 1998 Jan;10(1):146-52
9753121
Dev Biol. 1982 Jul;92(1):5-15
6179807
Cell. 1998 Jan 23;92(2):217-27
9458046
J Neurosci. 2007 Jun 20;27(25):6843-51
17581972
Development. 2005 Jan;132(2):323-34
15604101
Invest Ophthalmol Vis Sci. 1989 Mar;30(3):461-72
2494126
Invest Ophthalmol Vis Sci. 2010 Feb;51(2):782-9
19741242
Nat Neurosci. 2001 Jan;4(1):29-37
11135642
Mol Cell Neurosci. 1996 May;7(5):419-31
8812066
Cell. 1999 Mar 19;96(6):771-84
10102266
Dev Dyn. 2001 Oct;222(2):301-7
11668607
J Physiol Paris. 2002 Jan-Mar;96(1-2):91-8
11755787
Pain. 1982 Oct;14(2):105-120
7177676
Science. 2001 Apr 20;292(5516):507-10
11313496
Neuron. 1997 Sep;19(3):519-30
9331345
Exp Eye Res. 1994 Nov;59(5):597-605
9492761
Genome Biol. 2006;7(3):211
16584533
J Anat. 1951 Jan;85(1):68-99
14814019
Invest Ophthalmol Vis Sci. 1997 Sep;38(10):1944-53
9331258
Dev Biol. 2007 Jun 15;306(2):750-9
17499699
Development. 1988 Jan;102(1):101-6
3416767
J Comp Neurol. 2004 Feb 23;470(1):13-24
14755522
Mech Dev. 2004 Apr;121(4):315-24
15110042
Cell. 1999 Mar 19;96(6):785-94
10102267
Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4173-84
19387082
Invest Ophthalmol Vis Sci. 1999 Nov;40(12):2996-3005
10549663
Science. 2002 Dec 6;298(5600):1959-64
12471249
Neuron. 2004 Apr 22;42(2):213-23
15091338
Br J Clin Pharmacol. 2008 Nov;66(5):667-73
19032174
Invest Ophthalmol Vis Sci. 2000 Mar;41(3):692-702
10711683
Exp Neurol. 1980 Jul;69(1):196-201
7389846
Neuron. 2002 Jan 17;33(2):233-48
11804571
Neuron. 1997 Jun;18(6):889-97
9208857
Invest Ophthalmol Vis Sci. 1996 Mar;37(4):476-88
8595948
Dev Biol. 2008 Sep 1;321(1):162-74
18602913
Cold Spring Harb Symp Quant Biol. 1990;55:453-68
2132832
Exp Eye Res. 2003 May;76(5):521-42
12697417
Neuron. 2002 Jan 17;33(2):219-32
11804570
J Histochem Cytochem. 2002 Feb;50(2):235-44
11799142
J Neurosci. 2004 Jan 28;24(4):819-27
14749426
Nature. 2005 Jul 14;436(7048):193-200
16015319
Neurosurgery. 1978 May-Jun;2(3):252-8
104187
J Neurobiol. 2000 Dec;45(4):227-36
11077427
Invest Ophthalmol Vis Sci. 1993 Jan;34(1):137-44
7678833